- Home
- GSUN vs XBIO Comparison
GSUN vs XBIO Comparison
Compare GSUN & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- XBIO
- Stock Information
- Founded
- GSUN 1997
- XBIO N/A
- Country
- GSUN China
- XBIO United States
- Employees
- GSUN N/A
- XBIO N/A
- Industry
- GSUN Other Consumer Services
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GSUN Real Estate
- XBIO Health Care
- Exchange
- GSUN Nasdaq
- XBIO Nasdaq
- Market Cap
- GSUN 5.4M
- XBIO 6.3M
- IPO Year
- GSUN 2022
- XBIO N/A
- Fundamental
- Price
- GSUN $2.98
- XBIO $4.24
- Analyst Decision
- GSUN
- XBIO Hold
- Analyst Count
- GSUN 0
- XBIO 1
- Target Price
- GSUN N/A
- XBIO N/A
- AVG Volume (30 Days)
- GSUN 9.2K
- XBIO 11.0K
- Earning Date
- GSUN 02-05-2025
- XBIO 11-12-2024
- Dividend Yield
- GSUN N/A
- XBIO N/A
- EPS Growth
- GSUN N/A
- XBIO N/A
- EPS
- GSUN N/A
- XBIO N/A
- Revenue
- GSUN $6,336,931.00
- XBIO $2,523,427.00
- Revenue This Year
- GSUN N/A
- XBIO N/A
- Revenue Next Year
- GSUN N/A
- XBIO N/A
- P/E Ratio
- GSUN N/A
- XBIO N/A
- Revenue Growth
- GSUN N/A
- XBIO 7.15
- 52 Week Low
- GSUN $2.21
- XBIO $2.78
- 52 Week High
- GSUN $11.20
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- GSUN 54.39
- XBIO 53.05
- Support Level
- GSUN $2.64
- XBIO $3.93
- Resistance Level
- GSUN $2.94
- XBIO $4.32
- Average True Range (ATR)
- GSUN 0.19
- XBIO 0.25
- MACD
- GSUN 0.03
- XBIO 0.01
- Stochastic Oscillator
- GSUN 93.02
- XBIO 84.31
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is engaged in the provision of education and management services in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistic and consulting services. The company operates in two segments; Education segment and the Wellness segment. Majority of the revenue is generated from the Education segment which offers foreign language tutorial services and other education training management services in China. The wellness segment offers wellness service and related products.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.